Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Private Companies
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
PCCRYST
Stock Latest News
Private Companies
Leadership Profile Underscores Crystalys Therapeutics’ Clinical and Operational Expertise
3d ago
CRYST
Premium
Private Companies
Executive Leadership Profile Underscores Crystalys Therapeutics’ Gout-Focused Strategy
3d ago
CRYST
Premium
Private Companies
Crystalys Therapeutics Plans Investor Outreach at April Biopharma Conferences
7d ago
CRYST
Premium
Private Companies
Crystalys Therapeutics Highlights Gout–Kidney Link and Therapy Focus
8d ago
CRYST
Premium
Private Companies
Crystalys Therapeutics Highlights Strategic Focus on Gout and Kidney-Linked Hyperuricemia
9d ago
CRYST
Premium
Private Companies
Crystalys Therapeutics Backs European Crystal Disease Workshop in Paris
29d ago
CRYST
Premium
Private Companies
Crystalys Therapeutics Backs European Crystal Network Workshop 2026
29d ago
CRYST
Premium
Private Companies
Crystalys Therapeutics Emphasizes Regulatory and Clinical Leadership in Gout Program
1M ago
CRYST
Premium
Private Companies
Crystalys Therapeutics Emphasizes Experienced Clinical Leadership in Gout Pipeline
1M ago
CRYST
Premium
Private Companies
Crystalys Therapeutics Emphasizes Regulatory Leadership in Gout Drug Development
2M ago
CRYST
Premium
Private Companies
Crystalys Therapeutics Emphasizes CMO’s Regulatory Track Record in Gout Drug Development
2M ago
CRYST
Premium
Private Companies
Experienced Clinical Leadership Underscores Crystalys Therapeutics’ Gout Drug Development
2M ago
CRYST
Premium
Private Companies
Crystalys Therapeutics Emphasizes Regulatory and Clinical Leadership in Gout Program
2M ago
CRYST
Premium
Private Companies
Crystalys Therapeutics Adds Former Horizon CEO Tim Walbert to Board
2M ago
CRYST
Premium
Private Companies
Biotech Sentiment and M&A Momentum Framed as Supporting Crystalys Growth Outlook
2M ago
CRYST
Premium
Private Companies
Crystalys Therapeutics Advances Global Phase 3 Program as RUBY Gout Trial Begins Dosing in Europe
2M ago
CRYST
Premium
Private Companies
Crystalys Therapeutics Appoints Veteran CFO as It Advances Dotinurad Toward Late-Stage Milestones
3M ago
CRYST
Premium
Private Companies
Crystalys Therapeutics Names Veteran Deal-Maker Justin Thacker as CFO to Steer Phase 3 Gout Franchise and Financing Strategy
3M ago
CRYST
Premium
Private Companies
Crystalys Therapeutics – Weekly Recap
3M ago
CRYST
Premium
Private Companies
Crystalys Therapeutics Highlights CEO Participation in Longwood Healthcare Leaders Late-Stage Asset Discussion
3M ago
CRYST
Premium
Private Companies
Crystalys Therapeutics Highlights Gout Pipeline at J.P. Morgan Healthcare Conference
3M ago
CRYST
Premium
Private Companies
Crystalys Therapeutics Secures $205 Million Series A to Advance Global Phase 3 Gout Program
3M ago
CRYST
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >
You need to enable JavaScript to run this app.
